Cargando…
GDF15 acts synergistically with liraglutide but is not necessary for the weight loss induced by bariatric surgery in mice
OBJECTIVE: Analogues of GDF15 (Growth Differentiation Factor 15) are promising new anti-obesity therapies as pharmacological treatment with GDF15 results in dramatic reductions of food intake and body weight. GDF15 exerts its central anorexic effects by binding to the GFRAL receptor exclusively expr...
Autores principales: | Frikke-Schmidt, Henriette, Hultman, Karin, Galaske, Joseph W., Jørgensen, Sebastian B., Myers, Martin G., Seeley, Randy J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407365/ https://www.ncbi.nlm.nih.gov/pubmed/30685336 http://dx.doi.org/10.1016/j.molmet.2019.01.003 |
Ejemplares similares
-
Weight Loss Induced by Bariatric Surgery Restricts Hepatic GDF15 Expression
por: Adolph, Timon E., et al.
Publicado: (2018) -
SUN-LB100 GDF15 May Be Regulated by Cortisol After Sleeve Bariatric Surgery GDF15 May Be Regulated by Cortisol After Sleeve Bariatric Surgery
por: Dias, Jenny Pena, et al.
Publicado: (2020) -
SUN-269 Activation of GFRAL Neurons Decreases Food Intake via Aversive Pathways
por: Sabatini, Paul, et al.
Publicado: (2020) -
Pharmacological but not physiological GDF15 suppresses feeding and the motivation to exercise
por: Klein, Anders B., et al.
Publicado: (2021) -
Improved in vivo imaging method for individual islets across the mouse pancreas reveals a heterogeneous insulin secretion response to glucose
por: Frikke-Schmidt, Henriette, et al.
Publicado: (2021)